Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | aldo-keto reductase family 1, member C3 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Leishmania major | aldo-keto reductase-like protein | aldo-keto reductase family 1, member C3 | 323 aa | 325 aa | 34.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | eukaryotic initiation factor 4A | 0.0148 | 0.5393 | 1 |
Mycobacterium tuberculosis | Probable cold-shock DeaD-box protein A homolog DeaD (ATP-dependent RNA helicase dead homolog) | 0.0148 | 0.5393 | 0.5393 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0148 | 0.5393 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0059 | 0 | 0.5 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0148 | 0.5393 | 0.5 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0148 | 0.5393 | 1 |
Giardia lamblia | Translation initiation factor eIF-4A, putative | 0.0148 | 0.5393 | 0.5 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0059 | 0 | 0.5 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0148 | 0.5393 | 0.5 |
Treponema pallidum | ATP-dependent RNA helicase | 0.0148 | 0.5393 | 0.5 |
Onchocerca volvulus | Eukaryotic initiation factor 4A homolog | 0.0148 | 0.5393 | 0.5 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0059 | 0 | 0.5 |
Plasmodium vivax | RNA helicase-1, putative | 0.0148 | 0.5393 | 0.5 |
Toxoplasma gondii | eukaryotic initiation factor-4A, putative | 0.0148 | 0.5393 | 1 |
Echinococcus granulosus | eukaryotic initiation factor 4A | 0.0148 | 0.5393 | 1 |
Plasmodium falciparum | eukaryotic initiation factor 4A | 0.0148 | 0.5393 | 0.5 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0148 | 0.5393 | 0.5 |
Echinococcus granulosus | eukaryotic initiation factor 4A III | 0.0148 | 0.5393 | 1 |
Brugia malayi | eukaryotic initiation factor 4A | 0.0148 | 0.5393 | 0.5 |
Entamoeba histolytica | DEAD/DEAH box helicase, putative | 0.0148 | 0.5393 | 0.5 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0148 | 0.5393 | 0.5 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0148 | 0.5393 | 0.5 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0148 | 0.5393 | 1 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0148 | 0.5393 | 1 |
Echinococcus multilocularis | eukaryotic initiation factor 4A III | 0.0148 | 0.5393 | 1 |
Trypanosoma brucei | Eukaryotic initiation factor 4A-1 | 0.0148 | 0.5393 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.5393 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | > 2803 uM | The concentration of the compound effective to cause 50% hemolysis with sensitized sheep erythrocytes in the absence of complement | ChEMBL. | 12657256 |
IC50 (binding) | = 0.68 uM | Inhibition of recombinant human AKR1C3 | ChEMBL. | 16183274 |
IC50 (binding) | = 0.68 uM | Inhibition of recombinant human AKR1C3 | ChEMBL. | 16183274 |
IC50 (functional) | = 1401 uM | The concentration of the compound required to inhibit complement mediated hemolysis of sensitized sheep RBC | ChEMBL. | 12657256 |
Kd (binding) | > 10 mM | Dissociation constant after binding to human papillomavirus E2 DNA-binding domain (DBD) by observing the changes in [15N]-HSQC spectra. | ChEMBL. | 9379433 |
Kd (binding) | > 10 mM | Dissociation constant after binding to human papillomavirus E2 DNA-binding domain (DBD) by observing the changes in [15N]-HSQC spectra. | ChEMBL. | 9379433 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
4 literature references were collected for this gene.